Home Cart 0 Sign in  
X

[ CAS No. 4693-91-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 4693-91-8
Chemical Structure| 4693-91-8
Chemical Structure| 4693-91-8
Structure of 4693-91-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4693-91-8 ]

Related Doc. of [ 4693-91-8 ]

Alternatived Products of [ 4693-91-8 ]

Product Details of [ 4693-91-8 ]

CAS No. :4693-91-8 MDL No. :MFCD00075474
Formula : C9H9ClO2 Boiling Point : -
Linear Structure Formula :- InChI Key :CXJOONIFSVSFAD-UHFFFAOYSA-N
M.W : 184.62 Pubchem ID :2734688
Synonyms :

Calculated chemistry of [ 4693-91-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.7
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.01
Log Po/w (XLOGP3) : 2.4
Log Po/w (WLOGP) : 2.0
Log Po/w (MLOGP) : 1.74
Log Po/w (SILICOS-IT) : 2.67
Consensus Log Po/w : 2.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.67
Solubility : 0.396 mg/ml ; 0.00214 mol/l
Class : Soluble
Log S (Ali) : -2.59
Solubility : 0.47 mg/ml ; 0.00255 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0591 mg/ml ; 0.00032 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.25

Safety of [ 4693-91-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P305+P351+P338-P310 UN#:3265
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4693-91-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4693-91-8 ]
  • Downstream synthetic route of [ 4693-91-8 ]

[ 4693-91-8 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 4693-91-8 ]
  • [ 531-95-3 ]
Reference: [1] Organic Letters, 2006, vol. 8, # 24, p. 5441 - 5443
[2] Journal of the American Chemical Society, 2012, vol. 134, # 44, p. 18245 - 18248
[3] Tetrahedron, 2018, vol. 74, # 16, p. 2020 - 2029
  • 2
  • [ 4693-91-8 ]
  • [ 491-80-5 ]
Reference: [1] Journal of Organic Chemistry, 1945, vol. 10, p. 288,290
  • 3
  • [ 4693-91-8 ]
  • [ 2746-25-0 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 6, p. 707 - 710
  • 4
  • [ 104-01-8 ]
  • [ 4693-91-8 ]
YieldReaction ConditionsOperation in experiment
100% With thionyl chloride In benzene for 1 h; Heating / reflux 16.62g (0.1 mol) of 4-methoxyphenylacetic acid was dissolved in 10ml of benzene before 29ml (0. 2 mol) of thionylchloride was added thereto. Then, the solution was heated and refluxed, and was stirred for one hour. Thionylchloride remaining in the reaction solution and the solvent was condensed to be removed to obtain 4-methoxy-phenyl-acetyl chloride (compound I), a liquid phase product, at a quantitative yield. The product was used without purification.
100% for 2 h; Reflux General procedure: A mixture of various carboxylic acids (1.0mmol), an excess of thionyl chrolide (5mL) was refluxed for 2h and concentrated in vacuo to give corresponding acyl chloride (quant).
88% With thionyl chloride In <i>N</i>-methyl-acetamide; water (i)
4-Methoxyphenylacetyl chloride
Thionyl chloride (200 ml) was added to 4-methoxyphenylacetic acid (78 g, 0.47 mole) followed by one drop of dimethylformamide.
The reaction was heated at 65° C. for 4 hours and the solvent was removed under vacuum.
The residue was distilled in vacuo (water aspirator) at 135° C. to give the product as a red oil (75.9 g, 88percent).
Reference: [1] European Journal of Medicinal Chemistry, 2005, vol. 40, # 8, p. 764 - 771
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 22, p. 6160 - 6163
[3] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 10, p. 2899 - 2903
[4] Patent: WO2005/92896, 2005, A1, . Location in patent: Page/Page column 27
[5] Chinese Chemical Letters, 2013, vol. 24, # 8, p. 673 - 676
[6] Synthetic Communications, 1991, vol. 21, # 6, p. 819 - 826
[7] Journal of Organic Chemistry, 1986, vol. 51, # 6, p. 902 - 921
[8] Journal of Organic Chemistry, 1992, vol. 57, # 12, p. 3278 - 3286
[9] Journal of Organic Chemistry, 1984, vol. 49, # 21, p. 3881 - 3887
[10] Patent: US4798843, 1989, A,
[11] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1557 - 1564
[12] Monatshefte fuer Chemie, 1980, vol. 111, p. 81 - 92
[13] Organic Letters, 2009, vol. 11, # 12, p. 2659 - 2662
[14] Annales de Chimie (Cachan, France), 1940, vol. &lt;11&gt; 14, p. 5,54
[15] Journal of the American Chemical Society, 1946, vol. 68, p. 2592,2599
[16] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, # 10, p. 2407 - 2412
[17] Scientia Pharmaceutica, 2001, vol. 69, # 4, p. 329 - 350
[18] J. r., 1930, vol. &lt;2&gt; 126, p. 24,43
[19] Journal of the Chemical Society, 1913, vol. 103, p. 1038
[20] Journal of Medicinal Chemistry, 1990, vol. 33, # 5, p. 1496 - 1504
[21] Journal of Organic Chemistry, 1990, vol. 55, # 11, p. 3565 - 3568
[22] Journal of the American Chemical Society, 2003, vol. 125, # 23, p. 6856 - 6857
[23] Journal of Medicinal Chemistry, 2004, vol. 47, # 6, p. 1434 - 1447
[24] Archiv der Pharmazie, 1991, vol. 324, # 5, p. 283 - 286
[25] Tetrahedron, 1987, vol. 43, # 18, p. 4235 - 4239
[26] Tetrahedron Letters, 1989, vol. 30, # 13, p. 1605 - 1608
[27] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1176 - 1184
[28] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1985, vol. 24, p. 83 - 97
[29] Journal of Medicinal Chemistry, 1986, vol. 29, # 12, p. 2465 - 2472
[30] Journal of Medicinal Chemistry, 1985, vol. 28, # 8, p. 1106 - 1109
[31] Heterocycles, 2002, vol. 57, # 1, p. 39 - 46
[32] Journal of the American Chemical Society, 2006, vol. 128, # 21, p. 6938 - 6946
[33] Journal of Medicinal Chemistry, 1992, vol. 35, # 21, p. 3745 - 3754
[34] Indian Journal of Chemistry - Section B Organic Chemistry Including Medicinal Chemistry, 1990, vol. 29, # 11, p. 1034 - 1040
[35] Journal of Medicinal Chemistry, 1994, vol. 37, # 11, p. 1704 - 1711
[36] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1600 - 1607
[37] Journal of Organic Chemistry, 1996, vol. 61, # 1, p. 55 - 62
[38] Organic and Biomolecular Chemistry, 2005, vol. 3, # 11, p. 2129 - 2139
[39] Journal of Heterocyclic Chemistry, 1995, vol. 32, # 6, p. 1767 - 1773
[40] Journal of Medicinal Chemistry, 1996, vol. 39, # 7, p. 1509 - 1513
[41] Journal of Mass Spectrometry, 1996, vol. 31, # 7, p. 761 - 766
[42] Bioorganic and Medicinal Chemistry, 2002, vol. 10, # 8, p. 2779 - 2793
[43] Monatshefte fur Chemie, 2003, vol. 134, # 3, p. 403 - 409
[44] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 5, p. 821 - 823
[45] Synthesis, 2005, # 15, p. 2521 - 2526
[46] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2006, vol. 45, # 4, p. 1080 - 1085
[47] Journal of Medicinal Chemistry, 2006, vol. 49, # 12, p. 3563 - 3580
[48] Organic Letters, 2006, vol. 8, # 24, p. 5441 - 5443
[49] Journal of Medicinal Chemistry, 2000, vol. 43, # 4, p. 721 - 735
[50] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 11, p. 3703 - 3710
[51] Patent: EP954520, 2002, B1,
[52] Patent: WO2008/92873, 2008, A1, . Location in patent: Page/Page column 30
[53] Patent: US6348468, 2002, B1, . Location in patent: Page column 16
[54] Bulletin of the Chemical Society of Japan, 2009, vol. 82, # 2, p. 254 - 260
[55] Patent: EP1221441, 2002, A2, . Location in patent: Page 54
[56] Organic and Biomolecular Chemistry, 2009, vol. 7, # 17, p. 3561 - 3571
[57] Journal of Medicinal Chemistry, 2009, vol. 52, # 10, p. 3366 - 3376
[58] Journal of Organic Chemistry, 2010, vol. 75, # 1, p. 16 - 29
[59] Tetrahedron Letters, 2010, vol. 51, # 21, p. 2888 - 2891
[60] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 734 - 737
[61] Tetrahedron, 2010, vol. 66, # 26, p. 4882 - 4887
[62] Chemical Communications, 2010, vol. 46, # 21, p. 3666 - 3668
[63] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7089 - 7093
[64] European Journal of Pharmaceutical Sciences, 2011, vol. 42, # 1-2, p. 37 - 44
[65] Comptes Rendus Chimie, 2011, vol. 14, # 12, p. 1071 - 1079
[66] Organic and Biomolecular Chemistry, 2012, vol. 10, # 8, p. 1598 - 1601
[67] Organic Letters, 2012, vol. 14, # 8, p. 2154 - 2157
[68] Medicinal Chemistry Research, 2012, vol. 21, # 11, p. 3818 - 3825
[69] Journal of Medicinal Chemistry, 2013, vol. 56, # 1, p. 254 - 263
[70] Journal of the American Chemical Society, 2012, vol. 134, # 44, p. 18245 - 18248
[71] Chemical Communications, 2013, vol. 49, # 16, p. 1654 - 1656
[72] Journal of the American Chemical Society, 2013, vol. 135, # 19, p. 7304 - 7311
[73] European Journal of Organic Chemistry, 2013, # 16, p. 3271 - 3277
[74] Journal of Medicinal Chemistry, 2013, vol. 56, # 13, p. 5351 - 5381
[75] Chemistry - A European Journal, 2013, vol. 19, # 46, p. 15565 - 15571
[76] Organic and Biomolecular Chemistry, 2013, vol. 11, # 48, p. 8375 - 8386
[77] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2755 - 2772
[78] Journal of Medicinal Chemistry, 2014, vol. 57, # 15, p. 6479 - 6494
[79] Tetrahedron Letters, 2015, vol. 56, # 12, p. 1575 - 1580
[80] Medicinal Chemistry, 2014, vol. 10, # 8, p. 810 - 823
[81] Letters in Drug Design and Discovery, 2015, vol. 12, # 3, p. 190 - 205
[82] Chemistry - An Asian Journal, 2015, vol. 10, # 4, p. 925 - 937
[83] RSC Advances, 2015, vol. 5, # 88, p. 72373 - 72386
[84] Patent: EP2949651, 2015, A1, . Location in patent: Paragraph 0087
[85] Angewandte Chemie - International Edition, 2015, vol. 54, # 50, p. 15051 - 15054[86] Angew. Chem., 2015, vol. 54-127, # 50, p. 15265 - 15268,4
[87] Molecules, 2016, vol. 21, # 3,
[88] Organic and Biomolecular Chemistry, 2016, vol. 14, # 24, p. 5477 - 5480
[89] MedChemComm, 2016, vol. 7, # 9, p. 1858 - 1869
[90] Journal of Molecular Structure, 2017, vol. 1138, p. 177 - 191
[91] European Journal of Organic Chemistry, 2017, vol. 2017, # 20, p. 2866 - 2870
[92] Tetrahedron Letters, 2017, vol. 58, # 29, p. 2835 - 2837
[93] Patent: CN106467499, 2017, A, . Location in patent: Paragraph 0022; 0025; 0026
[94] Patent: KR2017/4492, 2017, A, . Location in patent: Paragraph 0106; 0107
[95] Journal of Organic Chemistry, 2017, vol. 82, # 14, p. 7332 - 7345
[96] Molecules, 2017, vol. 22, # 5,
[97] Chemical Communications, 2017, vol. 53, # 78, p. 10812 - 10815
[98] Organic Letters, 2017, vol. 19, # 19, p. 5216 - 5219
[99] Journal of Medicinal Chemistry, 2017, vol. 60, # 23, p. 9769 - 9789
[100] Journal of the American Chemical Society, 2018, vol. 140, # 5, p. 1952 - 1955
[101] Advanced Synthesis and Catalysis, 2018, vol. 360, # 5, p. 965 - 971
[102] Tetrahedron, 2018, vol. 74, # 16, p. 2020 - 2029
[103] Angewandte Chemie - International Edition, 2018, vol. 57, # 30, p. 9425 - 9429[104] Angew. Chem., 2018, vol. 130, # 30, p. 9569 - 9573,5
[105] Tetrahedron Letters, 2018, vol. 59, # 30, p. 2913 - 2916
[106] Fitoterapia, 2018, vol. 129, p. 257 - 266
[107] Angewandte Chemie - International Edition, 2018, vol. 57, # 38, p. 12347 - 12351[108] Angew. Chem., 2018, vol. 130, # 38, p. 12527 - 12531,5
[109] Pharmaceutical Chemistry Journal, 2018, vol. 52, # 5, p. 424 - 437
[110] Patent: WO2007/102679, 2007, A1, . Location in patent: Page/Page column 68
  • 5
  • [ 104-01-8 ]
  • [ 79-04-9 ]
  • [ 4693-91-8 ]
Reference: [1] Patent: CN104370793, 2017, B, . Location in patent: Paragraph 0394-0396
  • 6
  • [ 872-50-4 ]
  • [ 104-01-8 ]
  • [ 4693-91-8 ]
Reference: [1] Patent: US4386206, 1983, A,
  • 7
  • [ 156-38-7 ]
  • [ 4693-91-8 ]
Reference: [1] Patent: CN106467499, 2017, A,
  • 8
  • [ 4693-91-8 ]
  • [ 6343-93-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 10, p. 3366 - 3376
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 734 - 737
[3] Molecules, 2016, vol. 21, # 3,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4693-91-8 ]

Aryls

Chemical Structure| 6834-42-0

[ 6834-42-0 ]

2-(3-Methoxyphenyl)acetyl chloride

Similarity: 0.97

Chemical Structure| 10313-60-7

[ 10313-60-7 ]

2-(3,4-Dimethoxyphenyl)acetyl chloride

Similarity: 0.90

Chemical Structure| 28033-63-8

[ 28033-63-8 ]

2-(2-Methoxyphenyl)acetyl chloride

Similarity: 0.88

Chemical Structure| 39188-62-0

[ 39188-62-0 ]

4-(Benzyloxy)phenylacetyl Chloride

Similarity: 0.86

Chemical Structure| 51091-84-0

[ 51091-84-0 ]

(S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride

Similarity: 0.86

Chlorides

Chemical Structure| 6834-42-0

[ 6834-42-0 ]

2-(3-Methoxyphenyl)acetyl chloride

Similarity: 0.97

Chemical Structure| 10313-60-7

[ 10313-60-7 ]

2-(3,4-Dimethoxyphenyl)acetyl chloride

Similarity: 0.90

Chemical Structure| 28033-63-8

[ 28033-63-8 ]

2-(2-Methoxyphenyl)acetyl chloride

Similarity: 0.88

Chemical Structure| 39188-62-0

[ 39188-62-0 ]

4-(Benzyloxy)phenylacetyl Chloride

Similarity: 0.86

Chemical Structure| 51091-84-0

[ 51091-84-0 ]

(S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride

Similarity: 0.86

Ethers

Chemical Structure| 6834-42-0

[ 6834-42-0 ]

2-(3-Methoxyphenyl)acetyl chloride

Similarity: 0.97

Chemical Structure| 10313-60-7

[ 10313-60-7 ]

2-(3,4-Dimethoxyphenyl)acetyl chloride

Similarity: 0.90

Chemical Structure| 28033-63-8

[ 28033-63-8 ]

2-(2-Methoxyphenyl)acetyl chloride

Similarity: 0.88

Chemical Structure| 39188-62-0

[ 39188-62-0 ]

4-(Benzyloxy)phenylacetyl Chloride

Similarity: 0.86

Chemical Structure| 51091-84-0

[ 51091-84-0 ]

(S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride

Similarity: 0.86

Acyl Chlorides

Chemical Structure| 6834-42-0

[ 6834-42-0 ]

2-(3-Methoxyphenyl)acetyl chloride

Similarity: 0.97

Chemical Structure| 10313-60-7

[ 10313-60-7 ]

2-(3,4-Dimethoxyphenyl)acetyl chloride

Similarity: 0.90

Chemical Structure| 28033-63-8

[ 28033-63-8 ]

2-(2-Methoxyphenyl)acetyl chloride

Similarity: 0.88

Chemical Structure| 39188-62-0

[ 39188-62-0 ]

4-(Benzyloxy)phenylacetyl Chloride

Similarity: 0.86

Chemical Structure| 51091-84-0

[ 51091-84-0 ]

(S)-2-(6-Methoxynaphthalen-2-yl)propanoyl chloride

Similarity: 0.86